Cannabis use disorder (CUD) is the clinical term for cannabis addiction. Treatment rests on behavioral therapy. No medication holds FDA approval for CUD. Care level tracks severity: mild cases can start with outpatient therapy, and heavy daily use with failed quit attempts may need intensive outpatient or residential care.

cannabis use disorder symptoms

How common is cannabis use disorder?

NIDA estimates about 30% of people who use cannabis develop some degree of CUD. Starting before age 18 raises risk four to seven times compared with adult onset. DSM-5 requires two or more of 11 criteria within 12 months for a diagnosis.

how to know if you have cannabis addiction

Does cannabis withdrawal need treatment?

For some people, yes. DSM-5 lists cannabis withdrawal as a diagnosis. Symptoms start 24 to 72 hours after the last use, peak in the first week, and ease over one to two weeks. Signs include irritability, anxiety, sleep trouble, lower appetite, craving, headache, and sweating. Supportive care covers hydration, a sleep routine, and short-term symptom relief. Inpatient withdrawal management for cannabis alone is rare.

Cannabis Addiction vs Alcohol Addiction: Risk Comparison

Which therapies have evidence?

  • Cognitive behavioral therapy (CBT): targets triggers and coping skills. Courses run 6 to 12 sessions.
  • Motivational enhancement therapy (MET): two to four sessions. Builds a personal reason to cut down or stop.
  • Contingency management: vouchers or prizes for negative drug tests. Strong evidence in stimulant use disorder, and tested for cannabis.
  • Multidimensional family therapy: built for adolescents. 12 to 16 sessions.
  • CBT plus MET: the most studied package for adults with CUD.

What about medication?

No drug is FDA approved for CUD. Trials have tested off-label options:

Cannabis Addiction Withdrawal Symptoms: Timeline and Relief

  • N-acetylcysteine: studied in teens and young adults. Results are mixed.
  • Gabapentin: small trials on withdrawal sleep and craving.
  • Topiramate: cut use in some trials. Side effects limit its role.
  • Varenicline: tested for cannabis. Results do not support routine use.

Ask a prescriber about off-label use. The evidence base is weaker than for opioid or alcohol use disorder.

Levels of care

  1. Screening and brief intervention: one or two visits. Fits mild cases.
  2. Outpatient therapy: one session per week for 8 to 16 weeks.
  3. Intensive outpatient (IOP): 9 to 12 hours per week for 6 to 12 weeks.
  4. Residential: 24-hour care. Used when outpatient care fails or co-occurring conditions are unstable.

Peer support

SMART Recovery, Marijuana Anonymous, Refuge Recovery, and 12-step groups run free meetings. Data on cannabis outcomes is thin. Attendance tracks with lower use in some studies.

How to choose a program

Start with a clinician who screens against DSM-5 criteria. Ask about co-occurring anxiety, depression, or sleep disorders, since these drive relapse. Ask how progress gets measured, such as self-report plus urine tests. Ask about cost and insurance. Most US health plans cover CUD treatment as a mental health service.